Wednesday, 3 January 2018

Is the $850,000 price tag for a blindness-curing gene therapy a sign of future medical costs?

Each single dose of Luxturna, a gene therapy treating an inherited vision disorder, is set to ...

A recently approved gene therapy promising to restore vision in people with a rare genetic disease has just been priced at $850,000 per treatment. With more revolutionary gene therapies on the horizon promising one-off curative treatments some are asking how patients are expected to afford these exorbitantly priced drugs.

.. Continue Reading Is the $850,000 price tag for a blindness-curing gene therapy a sign of future medical costs?

Category: Medical

Tags: Related Articles:

from New Atlas http://ift.tt/2lPUSjU

No comments:

Post a Comment